A Vaccine Targeted at CETP Alleviates High Fat and High Cholesterol Diet-Induced Atherosclerosis and Non-Alcoholic Steatohepatitis in Rabbit

Future of Cholesteryl Ester Transfer Protein Inhibitors

(2014) Daniel J. Rader et al.   Annual Review of Medicine

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

(2012) Lokpal S. Bhatia et al.   EUROPEAN HEART JOURNAL

Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice

(2012) Veerle Bieghs et al.   HEPATOLOGY

Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk

(2012) Philip J. Barter et al.   JOURNAL OF LIPID RESEARCH

Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein

(2012) Lei Zhang et al.   Nature Chemical Biology

Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts

(2012) Andrew M. Cheng et al.   PLoS One

A novel synthetic bipartite carrier protein for developing glycotope-based vaccines

(2012) Hsiao-Ling Chiang et al.   VACCINE

NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages

(2011) Veerle Bieghs et al.   ATHEROSCLEROSIS

A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits

(2010) Tomohiro Ogawa et al.   AMERICAN JOURNAL OF PATHOLOGY

Anti-inflammatory effects of apolipoprotein A-I in the rabbit

(2010) Sanjay Patel et al.   ATHEROSCLEROSIS

Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?

(2010) Diego Lucero et al.   CLINICA CHIMICA ACTA

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

(2010) Brent A. Neuschwander-Tetri et al.   HEPATOLOGY

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention

(2010) Kiran Musunuru   LIPIDS

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

(2010) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism

(2009) Margaret E. Brousseau et al.   JOURNAL OF LIPID RESEARCH

Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis

(2008) Stephen J. Nicholls et al.   CIRCULATION